169 related articles for article (PubMed ID: 33165720)
41. Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
Cheng J; Liu B; Wang B; Long X; Li Z; Chen R; Wu R; Xu L
BMC Cancer; 2021 Oct; 21(1):1078. PubMed ID: 34615494
[TBL] [Abstract][Full Text] [Related]
42. Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience.
Raspagliesi F; Bogani G; Spinillo A; Ditto A; Bogliolo S; Casarin J; Leone Roberti Maggiore U; Martinelli F; Signorelli M; Gardella B; Chiappa V; Scaffa C; Ferrero S; Cromi A; Lorusso D; Ghezzi F
Eur J Surg Oncol; 2017 Nov; 43(11):2150-2156. PubMed ID: 28927778
[TBL] [Abstract][Full Text] [Related]
43. International radical trachelectomy assessment: IRTA study.
Salvo G; Ramirez PT; Leitao M; Cibula D; Fotopoulou C; Kucukmetin A; Rendon G; Perrotta M; Ribeiro R; Vieira M; Baiocchi G; Falconer H; Persson J; Wu X; Căpilna ME; Ioanid N; Mosgaard BJ; Berlev I; Kaidarova D; Olawaiye AB; Liu K; Nobre SP; Kocian R; Saso S; Rundle S; Noll F; Tsunoda AT; Palsdottir K; Li X; Ulrikh E; Hu Z; Pareja R
Int J Gynecol Cancer; 2019 Mar; 29(3):635-638. PubMed ID: 30765489
[TBL] [Abstract][Full Text] [Related]
44. Neoadjuvant Platinum-based Chemotherapy Followed by Radical Hysterectomy for Stage Ib2-IIb Adenocarcinoma of the Uterine Cervix - An Italian Multicenter Retrospective Study.
Gadducci A; Landoni F; Cosio S; Zizioli V; Zola P; Ferrero AM; Lapresa MT; Maggino T; Sartori E
Anticancer Res; 2018 Jun; 38(6):3627-3634. PubMed ID: 29848719
[TBL] [Abstract][Full Text] [Related]
45. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.
Benedetti-Panici P; Greggi S; Colombo A; Amoroso M; Smaniotto D; Giannarelli D; Amunni G; Raspagliesi F; Zola P; Mangioni C; Landoni F
J Clin Oncol; 2002 Jan; 20(1):179-88. PubMed ID: 11773168
[TBL] [Abstract][Full Text] [Related]
46. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
[TBL] [Abstract][Full Text] [Related]
47. A prospective randomized controlled study on multiple neoadjuvant treatments for patients with stage IB2 to IIA cervical cancer.
Wen H; Wu X; Li Z; Wang H; Zang R; Sun M; Huang X; Zhang Z; Cai S
Int J Gynecol Cancer; 2012 Feb; 22(2):296-302. PubMed ID: 22274319
[TBL] [Abstract][Full Text] [Related]
48. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer.
Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502
[TBL] [Abstract][Full Text] [Related]
49. The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer.
Yoshida K; Kajiyama H; Yoshihara M; Tamauchi S; Ikeda Y; Yoshikawa N; Nishino K; Niimi K; Suzuki S; Kikkawa F
Int J Clin Oncol; 2020 Feb; 25(2):384-390. PubMed ID: 31552530
[TBL] [Abstract][Full Text] [Related]
50. Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery.
Zannoni GF; Petrillo M; Vellone VG; Martinelli E; Chiarello G; Ferrandina G; Scambia G
Hum Pathol; 2014 Sep; 45(9):1872-8. PubMed ID: 24997647
[TBL] [Abstract][Full Text] [Related]
51. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
52. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
[TBL] [Abstract][Full Text] [Related]
53. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer.
Cusimano MC; Baxter NN; Gien LT; Moineddin R; Liu N; Dossa F; Willows K; Ferguson SE
Am J Obstet Gynecol; 2019 Dec; 221(6):619.e1-619.e24. PubMed ID: 31288006
[TBL] [Abstract][Full Text] [Related]
54. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
55. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
56. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
[TBL] [Abstract][Full Text] [Related]
57. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
[TBL] [Abstract][Full Text] [Related]
58. Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer.
Sakuragi N; Kato T; Shimada C; Kaneuchi M; Todo Y; Mitamura T; Takeda M; Kudo M; Murakami G; Watari H
JAMA Netw Open; 2020 May; 3(5):e204307. PubMed ID: 32379332
[TBL] [Abstract][Full Text] [Related]
59. Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer.
Minig L; Zanagnolo V; Cárdenas-Rebollo JM; Colombo N; Maggioni A
Eur J Surg Oncol; 2016 Sep; 42(9):1372-7. PubMed ID: 27247200
[TBL] [Abstract][Full Text] [Related]
60. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
Gynecol Oncol; 2019 Sep; 154(3):547-553. PubMed ID: 31272738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
